BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 11288127)

  • 1. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
    Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
    Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
    Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
    Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
    J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the RhD genotype in fetuses at risk for RhD hemolytic disease.
    Spence WC; Maddalena A; Demers DB; Bick DP
    Obstet Gynecol; 1995 Feb; 85(2):296-8. PubMed ID: 7824249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The applicability of different PCR-based methods for fetal RHD and K1 genotyping: a prospective study.
    Faas BH; Maaskant-Van Wijk PA; von dem Borne AE; van der Schoot CE; Christiaens GC
    Prenat Diagn; 2000 Jun; 20(6):453-8. PubMed ID: 10861708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rh system genotyping in amniotic fluid].
    Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Martino W; Racca A
    Medicina (B Aires); 2001; 61(1):76-8. PubMed ID: 11265629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
    Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
    Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
    Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
    Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
    Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal determination of the fetal RhD blood group by multiplex PCR: a 7-year Portuguese experience.
    Pereira JC; Couceiro AB; Cunha EM; Machado AI; Tamagnini GP; Martins NP; Ribeiro ML
    Prenat Diagn; 2007 Jul; 27(7):633-7. PubMed ID: 17497744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal determination of fetal RhD (rhesus positive) type by an amplification of DNA.
    Kvasnicka J; Rypácková B; Calda P; Hájek Z
    Sb Lek; 1998; 99(1):13-20. PubMed ID: 9748794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.
    Minon JM; Gerard C; Senterre JM; Schaaps JP; Foidart JM
    Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
    Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M
    BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive blood group genetics in hemolytic disease of the fetus and newborn: a 10-year review of a laboratory evaluation of amniotic fluid-derived DNA.
    Seto E; Fernandes BJ; Wang C; Denomme GA
    Prenat Diagn; 2007 Nov; 27(11):1017-23. PubMed ID: 17705237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
    Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
    N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
    Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
    Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal RhD genotyping by analysis of maternal blood. A case report.
    Tóth T; Papp C; Tóth-Pál E; Nagy B; Papp Z
    J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.